Amarin News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Amarin Corp PLC AMRN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.55 -8.16% 6.19 17:39:40
Open Price Low Price High Price Close Price Prev Close
6.9181 6.17 6.99 6.19 6.74
more quote information »

Recent News

Date Time Source Heading
3/01/20216:28IHNWFeaturedEmerging Growth Conference 2 Announced for March 3, 2021 Niche Companies in Technology, AR, eCommerce, Beverage and more ....
3/01/20213:56IHNWFeaturedManganese X Notes and Applauds President Biden's Executive Order to Secure America's Critical Supply Chains for Manganese and Electric Vehicle Batteries
3/01/20219:00IHNWFeaturedAmerican Green, Inc.™ (OTC:ERBB) Issues Update on U.S. Cannabis Cultivation Expansion
2/25/202109:48SEEKAmarin Q4 results led by strong Vascepa sales
2/25/202106:07EDGARCurrent Report Filing (8-k)
2/25/202105:58SEEKAmarin EPS beats by $0.04, beats on revenue
2/25/202105:55GLOBEAmarin Reports Fourth Quarter and Full Year 2020 Financial..
2/24/202111:55SEEKAmarin Q4 2020 Earnings Preview
2/22/202106:18IHNWNextech AR (OTCQB: NEXCF) $13 million Deal, Guidance to..
2/18/202106:05GLOBEAmarin to Present at Two Upcoming Investor Conferences
2/17/202108:05GLOBEAmarin to Report Fourth Quarter and Full Year 2020 Results..
2/12/202106:26IHNWNextech AR (OTCQB: NEXCF) 2021 Guidance $50-60 Million..
2/09/202107:00GLOBEAmarin Provides Update on VASCEPA® (Icosapent Ethyl)..
1/29/202117:01EDGARCurrent Report Filing (8-k)
1/29/202112:51GLOBEAmarin Receives Positive CHMP Opinion for Icosapent Ethyl..
1/28/202106:30PRNCAVASCEPA® (Icosapent Ethyl) Receives Further Inclusions in..
1/25/202119:35GLOBEAmarin Expands Cardiovascular Risk Reduction Patent..
1/21/202116:30GLOBEIcosapent Ethyl Included in the Chinese Society of..
1/07/202108:00IHNWThe FDA Calendar Review Dates Can Play a Big Role in Timing..
1/07/202106:16EDGARCurrent Report Filing (8-k)
1/07/202106:05GLOBEAmarin Provides Preliminary 2020 Results and 2021 Outlook
1/04/202106:05GLOBEAmarin to Present at 39th Annual J.P. Morgan Healthcare..
12/14/202005:00GLOBEAmarin Highlights Multiple VASCEPA® (Icosapent..
12/12/202021:30GLOBEAmarin Reports Encouraging Efficacy and Safety Results from..
12/07/202007:00GLOBEVASCEPA® (Icosapent Ethyl)-Related Scientific Findings to Be..
11/30/202019:54GLOBEAmarin Files Patent Infringement Lawsuit Against Hikma
11/24/202006:05GLOBEAmarin to Present at Piper Sandler’s 32nd Annual Healthcare..
11/19/202018:30GLOBEAmarin Shares Topline Data from Partner’s Pivotal Phase 3..
11/18/202007:00GLOBEMultiple New VASCEPA® (Icosapent Ethyl)-Related Scientific..
11/13/202010:00GLOBEVASCEPA® (Icosapent Ethyl) Found to Significantly Reduce..
11/11/202016:30GLOBEAmarin to Present at the Stifel 2020 Virtual Healthcare and ..
11/09/202006:00IHNWEpazz, Inc. (OTC Pink: EPAZ) and Zoom (NASDAQ: ZM) for a..
11/05/202006:00GLOBEAmarin Reports Third Quarter 2020 Financial Results and..
10/29/202007:00GLOBENew VASCEPA® (Icosapent Ethyl)-Related Scientific Findings..
10/26/202007:00GLOBEVASCEPA® (Icosapent Ethyl) Found to Significantly Reduce..
10/23/202007:00GLOBEU.S. Veterans with Decreased Renal Function Shown to Be at..
10/19/202007:00GLOBEAmarin to Report Third Quarter 2020 Results and Host..
10/15/202016:30GLOBEVASCEPA® (Icosapent Ethyl) Found to Significantly Reduce..
10/05/202007:00GLOBELatest Research Evaluating VASCEPA® (Icosapent Ethyl)..
9/09/202007:00GLOBEAmarin to Present at the 2020 Cantor Virtual Global..
9/03/202016:21EDGARCurrent Report Filing (8-k)
9/03/202010:51GLOBEAmarin Provides Update Following Ruling in VASCEPA® ANDA..
9/03/202009:00IHNWTraders News Source Issues "Potential Home Run" New Research..
9/01/202016:30GLOBEAmarin Supports Latest Clinical Research Evaluating VASCEPA®..
8/29/202003:13GLOBEVASCEPA® (Icosapent Ethyl) Reported to Significantly Reduce..
8/17/202007:00GLOBELatest Clinical Research Evaluating VASCEPA® (Icosapent..
8/07/202012:12GLOBEAmarin Supports Investigator-Initiated Trial at Kaiser..
8/04/202006:30GLOBEAmarin Announces Plans to Maximize Blockbuster Potential..
8/04/202006:17EDGARQuarterly Report (10-q)
8/04/202006:11EDGARCurrent Report Filing (8-k)
8/04/202006:00GLOBEAmarin Reports Second Quarter 2020 Financial Results and..
7/27/202007:00GLOBEVASCEPA® (icosapent ethyl) Data from REDUCE-IT® REVASC,..
7/21/202016:15GLOBEAmarin to Report Second Quarter 2020 Results and Host..
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.